GlassScriptPhysician profile
Laura D Clark
NPI 1588683973
$168,179.55
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118K · 2020: $32K · 2021: $12K · 2022: $313 · 2023: $5,456 · 2024: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,815 · Travel and Lodging: $1,243 · Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,815.00 |
| Travel and Lodging | $1,243.00 |
| Food and Beverage | $585.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $130,551.12 | 2019-2024 | Bridion |
| Covidien LP | $25,545.07 | 2019-2020 | |
| Medtronic, INC. | $7,072.83 | 2021-2022 | |
| Acelrx Pharmaceuticals, INC. | $3,773.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $600.70 | 2020-2024 | Exparel |
| Mallinckrodt Enterprises LLC | $120.12 | 2019 | |
| Chiesi USA, INC. | $117.01 | 2023 | Cleviprex |
| Heron Therapeutics, INC. | $112.14 | 2022 | |
| Masimo Corporation | $87.28 | 2023 | Set and Rainbow Set |
| Fisher & Paykel Healthcare INC | $49.65 | 2023-2024 | Fisher & Paykel Healthcare |
| Draeger Medical Systems, INC | $29.39 | 2023 | Anesthesia, Apollo |
| Ge Healthcare | $24.17 | 2022 | |
| Teleflex LLC | $18.44 | 2023 | Rusch |
| Trevena, INC. | $17.69 | 2021 | |
| Eagle Pharmaceuticals, INC. | $17.40 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $17.04 | 2024 | |
| Edwards Lifesciences Corporation | $13.78 | 2020 | |
| Karl Storz Endoscopy-America | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.